The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products.Bioprocess is a technique that produces biological materials such as a genetically engineered microbial strain for commercial use. For example, commercially useful chemicals are produced through bioprocess techniques such as microbial fermentation or degradation. The traditional approaches in bioprocessing involve stainless steel equipment that are not just difficult to maintain but also time-consuming and costly.Some of the advantages of single-use technologies over stainless steel technology are

given in the figure below. These benefits are significant, particularly when it comes to small-volume manufacturing in modular facilities.

PART 01: Executive summary 6

PART 02: Scope of the report 19

PART 03: Research Methodology 24

PART 04: Introduction 27

Key market highlights 27

PART 05: Market landscape 28

Market overview 28

Market size and forecast 29

Five forces analysis 32

PART 06: Market segmentation by application 33

Market overview 33

mAB production 34

Vaccine production 35

Plant cell cultivation 36

PSCTs 37

Others 38

PART 07: Market segmentation by product type 40

Market overview 40

Bags and mixers 41

Bioreactors and fermenters 42

Filtration devices and sampling systems 43

Bioprocess containers 44

Tubing systems (connectors/pipes) 45

Others 46

PART 08: Market segmentation by end-users 47

Market overview 47

Pharmaceutical companies 48

CROs & CMOs 49

Biotechnology companies 50

Academic and research institutions 51

PART 09: Geographical segmentation 52

Market overview 52

Americas 53

EMEA 54

APAC 55

PART 10: Decision framework 56

PART 11: Drivers and challenges 58

Market drivers 59

Impact of drivers on key customer segments 62

Market challenges 63

Impact of challenges on key customer segments 66

PART 12: Market trends 67

Increasing adoption of single-use bioprocessing in preclinical

and commercial stage 67

Emergence of downstream disposables 68

SUT aiding continuous bioprocessing 70

PART 13: Vendor landscape 71

Competitive scenario 71

PART 14: Key vendor analysis 72

Danaher 72

GE Healthcare 74

Merck 77

Sartorius 79

Thermo Fisher Scientific 82

Other prominent vendors 84

PART 15: Appendix 86

List of abbreviations 86

PART 16: Explore Technavio 87